Minerva Surgical, Inc. (UTRS)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jul 22, 2025

Minerva Surgical Company Description

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States.

The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps.

Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices.

The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Minerva Surgical, Inc.
CountryUnited States
Founded2008
IndustryMedical Devices
SectorHealthcare
Employees174
CEODarin Hammers

Contact Details

Address:
4255 Burton Drive
Santa Clara, Delaware 95054
United States
Phone855 646 7874
Websiteminervasurgical.com

Stock Details

Ticker SymbolUTRS
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS60343F1066
SIC Code3841

Key Executives

NamePosition
Darin HammersChief Executive Officer
Greg SimbroVice President of Finance
Wendy BowmanVice President of Human Resources
Dr. Evgueni V. Skalnyi M.D.Chief Medical Officer
Brent PalmisanoChief Commercial Officer
Joanne LongVice President of Corporate Controller